Loading...

SNOA SONOMA PHARMACEUTICALS INC Management Changes 8-K Filing

SNM

SN

SONOMA PHARMACEUTICALS INC

(SNOA)

2026 8-K

Management Changes

Investor Presentation Update

Equity Grant Report

Executive Departure

Management Changes

Investor Presentation Update

Stock Sale Agreement

Annual Meeting Results

Investor Presentation

Investor Presentation

Supply Agreement Update

Supply Agreement

Agreement Termination

Distribution Agreement

Equity Distribution

Stock Split Approval

Distribution Agreement

Equity Distribution Agreement

Investor Presentation

Investor Conferences

Delisting Notice

Equity Distribution Agreement

Regulation FD Disclosure

Agreement with NovaBay Phar...

Stock Options Grant

Equity Distribution Agreement

Amendment to Form 8-K

Investor Presentation

Investor Presentation

Management Changes

Amendment to At-The-Market ...

Distribution Agreement

Investor Presentation

External Links:

On January 28, 2026, Dr. Jay Birnbaum retired from Sonoma Pharmaceuticals' Board and will consult for one year, while Vanessa Jacoby was appointed as his replacement with an annual compensation of $32,500 plus stock options.

AI Assistant

SONOMA PHARMACEUTICALS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.